Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Autosomal recessive spastic paraplegia type 58 is a rare, complex subtype of hereditary spastic paraplegia characterized by variable onset of slowly progressive lower limb spasticity and weakness and prominent cerebellar ataxia, associated with gait disturbances, dysarthria, increased deep tendon reflexes and extensor plantar responses. Additional features may include involuntary movements (i.e. clonus, tremor, fasciculations, chorea), decreased vibration sense, oculomotor abnormalities (e.g. nystagmus) and distal amyotrophy in the upper and lower limbs.
Features include always present findings: Dysmetria, Dysarthria, and Gait ataxia; and very common findings: Head titubation, Horizontal nystagmus, Tremor, and Overactive reflexes (hyperreflexia). 19 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Brain and nerves | 11 | Brain shrinkage (cerebral atrophy), Babinski sign, Spastic ataxia |
KIF1C encodes kinesin family member 1C (1,103 aa). Motor required for the retrograde transport of Golgi vesicles to the endoplasmic reticulum. Has a microtubule plus end-directed motility Highest expression in Muscle Skeletal (308.2 TPM) and Brain Spinal cord cervical c-1 (252.4 TPM).
Spastic ataxia 2 is associated with mutations in the KIF1C gene on chromosome 17.
KIF1C is classified as a druggable target with score 0.0.
Genetic testing for KIF1C is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for spastic ataxia 2 has been reported in the published literature.
Phenotype severity distribution: 3 always present features, 4 very common features, 1 common feature.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for spastic ataxia 2.
42 publications have been identified in PubMed for spastic ataxia 2. Research spans Basic Science / Preclinical (33%), Case Report / Case Series (21%), and Clinical Trial Publication (14%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 14 | 33% |
Data assembled from 6 of 12 sources · Last updated Sep 20, 2026, 3:00 PM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Muscles |
4 |
Brain shrinkage (cerebral atrophy), Shrinkage of the cerebellum (cerebellar atrophy), Fasciculations |
Eyes | 1 | Horizontal nystagmus |
9 |
21% |
Clinical study results | 6 | 14% |
Disease patterns and progression | 5 | 12% |
Testing and diagnosis research | 3 | 7% |
Research summaries | 3 | 7% |
New treatment approaches | 2 | 5% |
Yeow D (2026). [PMID: 41353788](https://pubmed.ncbi.nlm.nih.gov/41353788/). *Annals of clinical and translational neurology*. [Case Report / Case Series]
Thomsen M (2026). [PMID: 41874815](https://pubmed.ncbi.nlm.nih.gov/41874815/). *Cerebellum*. [Case Report / Case Series]
Menden B (2026). [PMID: 41690933](https://pubmed.ncbi.nlm.nih.gov/41690933/). *Nature communications*. [Basic Science / Preclinical]
Maccora S (2026). [PMID: 41145127](https://pubmed.ncbi.nlm.nih.gov/41145127/). *Neuropediatrics*. [Review / Meta-Analysis]
Johari M (2026). [PMID: 41678358](https://pubmed.ncbi.nlm.nih.gov/41678358/). *Brain : a journal of neurology*. [Diagnostic / Biomarker]
Mitsutake A (2026). [PMID: 41236093](https://pubmed.ncbi.nlm.nih.gov/41236093/). *Annals of clinical and translational neurology*. [Epidemiology / Natural History]
Fortin J (2026). [PMID: 41669957](https://pubmed.ncbi.nlm.nih.gov/41669957/). *Movement disorders : official journal of the Movement Disorder Society*. [Case Report / Case Series]
Rocco A (2026). [PMID: 41883704](https://pubmed.ncbi.nlm.nih.gov/41883704/). *Neurol Genet*. [Basic Science / Preclinical]
Dash A (2026). [PMID: 41784076](https://pubmed.ncbi.nlm.nih.gov/41784076/). *Ann Indian Acad Neurol*. [Gene Therapy / Novel Therapeutics]
Liu Y (2026). [PMID: 42244714](https://pubmed.ncbi.nlm.nih.gov/42244714/). *bioRxiv*. [Basic Science / Preclinical]